SION
Sionna Therapeutics, Inc.
1W: +7.8%
1M: -0.6%
3M: -12.6%
YTD: -5.4%
1Y: +206.4%
$37.08
+2.32 (+6.67%)
After Hours: $36.70 (-0.38, -1.02%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Bullish
75
Insider+$40.4M
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.7B
52W Range7.255-45
Volume284,096
Avg Volume279,701
Beta4.04
Dividend—
Analyst Ratings
Company Info
CEOMichael Cloonan
Employees41
SectorHealthcare
IndustryBiotechnology
IPO Date2025-02-07
Websitesionnatx.com
21 Hickory Drive Suite 500
Waltham, MA 02451
US
Waltham, MA 02451
US
617 819 2020
About Sionna Therapeutics, Inc.
Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.
Latest News
Sionna Therapeutics (NASDAQ:SION) Trading Up 3.8% – Here’s What Happened
Sionna Therapeutics, Inc. (NASDAQ:SION) Receives Average Rating of “Moderate Buy” from Brokerages
Sionna Stock Is Up 144% This Past Year. Is the Biotech a Buy as One Fund Makes a $7 Million Bet?
This Investor Sold $5 Million of a Biotech Stock Up 118% in a Year, but Here's Why It Still Seems Bullish on Shares
Sionna Therapeutics, Inc. $SION Shares Sold by Atlas Venture Life Science Advisors LLC
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Fitzpatrick Jennifer | M-Exempt | 10,250 | $6.11 | 2026-03-05 |
| Fitzpatrick Jennifer | S-Sale | 10,250 | $33.86 | 2026-03-05 |
| Fitzpatrick Jennifer | M-Exempt | 10,250 | $6.11 | 2026-03-05 |
| ORBIMED ADVISORS LLC | S-Sale | 29,063 | $44.58 | 2026-02-03 |
| Thompson Peter A. | S-Sale | 29,063 | $44.58 | 2026-02-03 |